A utilização da toxina botulínica tipo A na técnica de harmonização facial e o papel do profissional farmacêutico: uma revisão.

Abstract

The aging process contributes to the population looking for prevention and treatment measures to contain changes that occur mainly in the face. The emergence and evolution of science enabled the development of facial harmonization techniques in order to reshape the face region and reduce the advances of deep wrinkles and expression lines. With the advancement of studies, it was observed that botulinum toxin type A has properties to prevent and smooth wrinkles, treat scars, correct facial asymmetries and gummy smile. In this work we carried out a literary research on the facial harmonization technique using botulinum toxin type A and the possibility of application by the pharmaceutical professional. Therefore, an integrative bibliographic research was carried out in the databases of Scielo, Scholar Google, Pubmed, Caps Periodics and in national and international health committees. The articles were found in full via the internet, in Portuguese, English and Spanish, which addressed studies on the use of botulinum toxin type A published in the last eight years (2013-2021). The terms used for the search are keywords or combinations of terms: harmonization, botox, aesthetic pharmacist, aging. A total of 72 publications were analyzed to carry out this review, among articles, resolutions and reports published in journals, government agencies and health committees. This bibliographic survey allowed us to visualize the comprehensive field of action in aesthetics for the pharmacist, especially in the application of botulinum toxin for the treatment of the most diverse imperfections on the face. We also highlighted the importance of using safety measures and studying the condition of each patient so as not to compromise their well-being and to present the best result. We can see that this is a very broad field of action that is developed mainly in Brazil, where the pharmaceutical professional can apply botulinum toxin type A supported by current legislation.